Problem statement: Answer the multiple-choice question.
Question: Which compound exhibits a -17.109% human ether-à-go-go related gene (hERG) inhibition at 10uM?
Constraint: You must select none, one or more options from a or b without using any other words.
Options:
a. CCCn1c(=O)c(C(=O)Nc2ncccc2O)c(O)c2ccccc21
b. C/C(=N\NS(=O)(=O)c1ccc(Br)cc1)c1ccc2c(c1)OCO2
Answer: b. C/C(=N\NS(=O)(=O)c1ccc(Br)cc1)c1ccc2c(c1)OCO2
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
C/C(=N\NS(=O)(=O)c1ccc(Br)cc1)c1ccc2c(c1)OCO2
C/C(=N\NS(=O)(=O)c1ccc(Br)cc1)c1ccc2c(c1)OCO2
N-[(E)-[1-(1,3-benzodioxol-5-yl)ethylidene]amino]-4-bromobenzenesulfonamide